About
Neuvogen is a biotechnology company developing therapeutic whole cell cancer vaccines designed to address the complexity and heterogeneity of solid tumors.
Explore Neuvogen's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.